CELL VIABILITY: AN INDISPENSABLE INDICATOR OF DRUG SAFETY & TOXICITY
Cell viability and proliferation are critical pieces of information for assessing drug safety and toxicity. Depending on the disease of interest, drug-development campaigns may seek to enhance cell repopulation, as in degenerative diseases, or inhibit it, as in cancer.
Our Ready-2-Go assay service provides multi-parameter assessments that quantitatively measure cell proliferation, apoptosis, and viability in multiple cell types.
KEY FEATURES
![]()
Choose A549, U-2 OS, or Hep G2 cells
![]()
Multiplexed measurements of proliferation, apoptosis, and cell viability
![]()
Only 4-6 weeks from assay to report
![]()
Option to bundle R2G Services or transition to Custom Services
BUILD A GENERAL FRAMEWORK OF TOXICITY
Bundle this service with our Ready-2-Go Mitochondrial Health Assay Service to gain a better understanding of your therapeutics' impact on cell viability.

RELATED READY-2-GO SERVICES
Browse related Ready-2-Go assay offerings. For custom assays, check out our Custom Services.
![]()
R2G MITOCHONDRIAL HEALTH
Screen for changes in mitochondrial membrane potential.
Learn more
![]()
R2G LUNG FIBROSIS
Stress fibers are measured in NHLFs.
Learn more
![]()
R2G NEUROTOXICITY
Multiplexed readouts of viability and apoptosis.
Learn more

